Phase-1 Molecular Toxicology's Series C Round

Phase-1 Molecular Toxicology raised a round of funding on November 22, 1999.

Phase-1 Molecular Toxicology is a Healthcare/Medical Facilities & Services company based in Santa Fe, New Mexico. Phase-1 Molecular Toxicology's investors include Oxford Bioscience Partners, Gimv and …

Articles about Phase-1 Molecular Toxicology's Series C Round: